Search Result(s)

There are 90 item(s) tagged with the keyword "Columbia Threadneedle Investments".

Displaying: 1 - 10 of 90

2026 Macroeconomic Outlook: Treading a finer line

Resilient growth and rising markets mask underlying structural tensions – the risks of a misstep are accumulating. We assess the balance for investors.

Tags: Columbia Threadneedle Investments
2026 Equity Outlook: Harnessing growth with a broad view

We maintain a constructive outlook for equities, with a broadening of opportunities for selective investment, backed by disciplined diversification.

Tags: Columbia Threadneedle Investments, Global Equity, Equity
Weekly Perspectives – Split signals: why the BoE is set to cut, while the Fed may have to wait

This week we focus on the diverging chances of a rate cut in December from the Bank of England (BoE) and the Federal Reserve (Fed).

Tags: Columbia Threadneedle Investments, Multi-Asset
Has QT pushed up gilt yields? Yes ... and more than the BoE would admit

The Chanceller’s job of balancing UK finances hasn’t been helped by gilts. Since the election in July 2024, borrowing costs have been higher than the government would like. But one question still gets too little scrutiny: to what degree is the BoE’s QT programme responsible?

Tags: Columbia Threadneedle Investments, Multi-Asset
Weekly Perspectives: Can we now move on from the UK budget?

Chancellor Rachel Reeves achieved her budgetary goals: – the OBR is happy, markets are calm, and Labour backbenchers are content. But is that good enough?

Tags: Columbia Threadneedle Investments, Multi-Asset
European improvement, not just US weakness

The region has exited post-Covid stagflation, with inflation falling and interest rates easing, so economic performance has turned round. America, by contrast, faces stagflation

Tags: Columbia Threadneedle Investments, Equity - Europe, Equity
Resilient European High Yield market looks beyond tariff uncertainty

We cannot ignore the dominant themes impacting markets across the world, but a resilient and supported European marketplace is well placed to prosper in these challenging times

Tags: Columbia Threadneedle Investments, Fixed Income - High Yield, Fixed income
Navigating the fog of tariffs in emerging market equities

We don’t pretend to have all the answers on China and the US, and we reserve the right to change our minds – especially as Donald Trump changes his. Amid such market volatility we are not making bold macro calls, instead our focus is on thoughtful, quality-led stock selection.

Tags: Columbia Threadneedle Investments, Equity
Japan: A timely opportunity to seize long-term potential

Fundamental backdrop remains solid – many companies are performing well and first quarter earnings were healthy. Shareholder interests remain to the fore with buybacks tripled year-on-year in April. Merger and acquisition activity has been widespread.

Tags: Columbia Threadneedle Investments, Equity
A bitter pill: what tariffs could mean for pharmaceutical firms and the wider healthcare industry

The US government’s proposal to impose tariffs on pharmaceutical imports has ignited a complex debate, intertwining economic, healthcare, and geopolitical considerations. While the initiative aims to bolster domestic manufacturing and reduce reliance on foreign supply chains, it also raises concerns about drug affordability and availability, and has broader implications for the healthcare system.

Tags: Columbia Threadneedle Investments, Fixed income

Displaying: 1 - 10 of 90